Allogeneic NK cell therapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Allogeneic NK cell therapy, covering 2013-08-19 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients [Phase 1, Phase 2]